Search research articles
Contact Us
Filters
Showing results (771-780 of 964) with videos related to
Page
of 97
Sort By:
Schizophrenia Bulletin
|
August 24, 2011
Neurocognitive predictors of work outcome in recent-onset schizophrenia
Keith H Nuechterlein, Kenneth L Subotnik, Michael F Green, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 15, 2020
Multiple Concurrent Illnesses Associated with Anemia in HIV-Infected and HIV-Exposed Uninfected Children Aged 6-59 Months, Hospitalized in Mozambique
Caitlyn Duffy, Darlenne B Kenga, Tebeb Gebretsadik, et al.
Journal of Psychiatric Research
|
March 5, 2013
Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome
Gregory P Strauss, William P Horan, Brian Kirkpatrick, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 19, 2023
Linking social motivation, general motivation, and social cognition to interpersonal functioning in schizophrenia: insights from exploratory graph analysis
Michal Hajdúk, Samuel J Abplanalp, Amy M Jimenez, et al.
Psychological Medicine
|
February 5, 2024
Social cognition and social motivation in schizophrenia and bipolar disorder: are impairments linked to the disorder or to being socially isolated?
Michael F Green, Jonathan K Wynn, Naomi I Eisenberger, et al.
Schizophrenia Research
|
January 18, 2020
Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia
Alexandra C Reed, Junghee Lee, Michael F Green, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 28, 2022
Health equity in the implementation of genomics and precision medicine: A public health imperative
Muin J Khoury, Scott Bowen, W David Dotson, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside
A Hageboutros, G R Hudes, J Brennan, et al.
JAMA Psychiatry
|
October 4, 2013
Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor
Hsien-Yuan Lane, Ching-Hua Lin, Michael F Green, et al.
Investigational New Drugs
|
January 1, 1996
Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas
R M Scher, R Kosierowski, C Lusch, et al.
Page
of 97
Search research articles
Search
Showing results (771-780 of 964) with videos related to
Sort By:
Page
of 97
Schizophrenia Bulletin
|
August 24, 2011
Neurocognitive predictors of work outcome in recent-onset schizophrenia
Keith H Nuechterlein, Kenneth L Subotnik, Michael F Green, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 15, 2020
Multiple Concurrent Illnesses Associated with Anemia in HIV-Infected and HIV-Exposed Uninfected Children Aged 6-59 Months, Hospitalized in Mozambique
Caitlyn Duffy, Darlenne B Kenga, Tebeb Gebretsadik, et al.
Journal of Psychiatric Research
|
March 5, 2013
Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome
Gregory P Strauss, William P Horan, Brian Kirkpatrick, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 19, 2023
Linking social motivation, general motivation, and social cognition to interpersonal functioning in schizophrenia: insights from exploratory graph analysis
Michal Hajdúk, Samuel J Abplanalp, Amy M Jimenez, et al.
Psychological Medicine
|
February 5, 2024
Social cognition and social motivation in schizophrenia and bipolar disorder: are impairments linked to the disorder or to being socially isolated?
Michael F Green, Jonathan K Wynn, Naomi I Eisenberger, et al.
Schizophrenia Research
|
January 18, 2020
Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia
Alexandra C Reed, Junghee Lee, Michael F Green, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 28, 2022
Health equity in the implementation of genomics and precision medicine: A public health imperative
Muin J Khoury, Scott Bowen, W David Dotson, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside
A Hageboutros, G R Hudes, J Brennan, et al.
JAMA Psychiatry
|
October 4, 2013
Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor
Hsien-Yuan Lane, Ching-Hua Lin, Michael F Green, et al.
Investigational New Drugs
|
January 1, 1996
Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas
R M Scher, R Kosierowski, C Lusch, et al.
Page
of 97